NeoGenomics (NEO) Tops Q3 EPS by 7c

NeoGenomics (NASDAQ: NEO) reported Q3 EPS of $0.00, $0.07 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $152 million versus the consensus estimate of $141.65 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)